Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Sponsor: Novartis Pharmaceuticals
Summary
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).
Official title: A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER)
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
1400
Start Date
2024-02-28
Completion Date
2030-09-20
Last Updated
2026-04-08
Healthy Volunteers
No
Conditions
Interventions
Ribociclib
Ribociclib 400 mg orally once daily on days 1-21 of a 28 day cycle followed by 7 days rest
Letrozole
Letrozole 2.5 mg orally once daily continuously
Ansastrozole
Anastrozole 1 mg orally once daily continuously.
Goserelin
Goserelin administered subcutaneously at 3.6 mg once every 4 weeks if the one-month depot formulation is used or at 10.8 mg once every 3 months if the three-month depot formulation is used
Leuprolide
Leuprolide administered subcutaneously at 3.75 mg once every 4 weeks if the one-month depot formulation is used or at 11.25 mg once every 3 months if the three-month depot formulation is used
Exemestane
Exemestane 25 mg once daily continuously
Locations (198)
Central Alabama Research
Birmingham, Alabama, United States
Alaska Oncology and Hematology LLC
Anchorage, Alaska, United States
Western Reg MC-COH Phoenix
Goodyear, Arizona, United States
CARTI Cancer Center
Little Rock, Arkansas, United States
Beverly Hills Cancer Center
Beverly Hills, California, United States
Onco Inst of Hope and Innovation
Cerritos, California, United States
City of Hope National Medical
Duarte, California, United States
Providence Medical Foundation
Fullerton, California, United States
Palo Alto Medical Foundation
Mountain View, California, United States
UC Irvine Medical Center
Orange, California, United States
Sutter Inst Medical Research
Sacramento, California, United States
School Of Medicine
Sacramento, California, United States
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Georgetown University Lombardi Cancer Center
Washington D.C., District of Columbia, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Holy Cross Health
Fort Lauderdale, Florida, United States
Memorial Cancer Institute
Hollywood, Florida, United States
Ocala Research Institute, Inc
Ocala, Florida, United States
Summit Cancer Care PC
Savannah, Georgia, United States
Affiliated Oncologists IL
Chicago, Illinois, United States
Hope And Healing Care
Hinsdale, Illinois, United States
Midwestern Reg MC COH Chicago
Zion, Illinois, United States
Investigative Clinical R of Indiana
Indianapolis, Indiana, United States
University of Iowa Health Care
Waukee, Iowa, United States
University of Kansas Cancer Center
Westwood, Kansas, United States
Cancer Center of Kansas
Wichita, Kansas, United States
Willis-Knighton Cancer Center
Shreveport, Louisiana, United States
Mercy Medical Center
Baltimore, Maryland, United States
Maryland Oncology Hematology P A
Silver Spring, Maryland, United States
Boston Medical Center
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Dana Farber Brigham Women Cancer
Milford, Massachusetts, United States
Minnesota Oncology Hematology P A
Minneapolis, Minnesota, United States
Jackson Oncology Associates
Jackson, Mississippi, United States
HCA Midwest Division
Kansas City, Missouri, United States
WA Uni School Of Med
St Louis, Missouri, United States
Intermountain Healthcare
Billings, Montana, United States
Nebraska Cancer Specialists
Omaha, Nebraska, United States
Renown Regional Medical Center
Reno, Nevada, United States
Summit Health
Florham Park, New Jersey, United States
The Valley Hospital
Ridgewood, New Jersey, United States
Presbyterian Medical Group
Albuquerque, New Mexico, United States
Queens Cancer Center of Queens Hospital
Jamaica, New York, United States
Optum Health
Lake Success, New York, United States
Mount Sinai School of Medicine
New York, New York, United States
Duke Cancer Network
Durham, North Carolina, United States
Cone Health Cancer Center
Greensboro, North Carolina, United States
Oncology Associates of Oregon PC
Eugene, Oregon, United States
Northwest Cancer Specialists
Portland, Oregon, United States
Oregon Oncology Specialists Salem
Salem, Oregon, United States
Consultants In Med Onco And Hema
Drexel Hill, Pennsylvania, United States
Univ of Pittsburg Med Ctr Pinnacle
Harrisburg, Pennsylvania, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Bon Secours St Francis Cancer Center
Greenville, South Carolina, United States
Lexington Medical Center
West Columbia, South Carolina, United States
Regional Medical Oncology NC
Wilson, South Carolina, United States
Sanford USD Medical Center
Sioux Falls, South Dakota, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
El Paso Texas Oncology
El Paso, Texas, United States
Kelsey Seybold Clinic
Houston, Texas, United States
University of Texas
Houston, Texas, United States
Texas Oncology P A Plano East
Plano, Texas, United States
Texas Oncology PA Tyler
Tyler, Texas, United States
Bon Secours Virginia Health System
Midlothian, Virginia, United States
Virginia Oncology Associates
Norfolk, Virginia, United States
Providence Regional Cancer System
Lacey, Washington, United States
Northwest Medical Specialties
Tacoma, Washington, United States
Novartis Investigative Site
Caba, Buenos Aires, Argentina
Novartis Investigative Site
Córdoba, Argentina
Novartis Investigative Site
Gateshead, New South Wales, Australia
Novartis Investigative Site
Tiwi, Northern Territory, Australia
Novartis Investigative Site
Clayton, Victoria, Australia
Novartis Investigative Site
East Melbourne, Victoria, Australia
Novartis Investigative Site
Victoria, British Columbia, Canada
Novartis Investigative Site
Halifax, Nova Scotia, Canada
Novartis Investigative Site
Oakville, Ontario, Canada
Novartis Investigative Site
Ottawa, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Québec, Quebec, Canada
Novartis Investigative Site
Beijing, Beijing Municipality, China
Novartis Investigative Site
Guangzhou, Guangdong, China
Novartis Investigative Site
Harbin, Heilongjiang, China
Novartis Investigative Site
Zhengzhou, Henan, China
Novartis Investigative Site
Zhengzhou, Henan, China
Novartis Investigative Site
Nanjing, Jiangsu, China
Novartis Investigative Site
Nanchang, Jiangxi, China
Novartis Investigative Site
Changchun, Jilin, China
Novartis Investigative Site
Jinan, Shandong, China
Novartis Investigative Site
Jinan, Shandong, China
Novartis Investigative Site
Jining, Shandong, China
Novartis Investigative Site
Chengdu, Sichuan, China
Novartis Investigative Site
Chengdu, Sichuan, China
Novartis Investigative Site
Ürümqi, Xinjiang, China
Novartis Investigative Site
Hangzhou, Zhejiang, China
Novartis Investigative Site
Hangzhou, Zhejiang, China
Novartis Investigative Site
Wenzhou, Zhejiang, China
Novartis Investigative Site
Beijing, China
Novartis Investigative Site
Beijing, China
Novartis Investigative Site
Guangzhou, China
Novartis Investigative Site
Qingdao, China
Novartis Investigative Site
Shanghai, China
Novartis Investigative Site
Shijiazhuang, China
Novartis Investigative Site
Tianjin, China
Novartis Investigative Site
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Novartis Investigative Site
Munich, Bavaria, Germany
Novartis Investigative Site
Regensburg, Bavaria, Germany
Novartis Investigative Site
Weiden in Der Oberpfalz, Bavaria, Germany
Novartis Investigative Site
Langen, Hesse, Germany
Novartis Investigative Site
Hildesheim, Lower Saxony, Germany
Novartis Investigative Site
Bergisch Gladbach, North Rhine-Westphalia, Germany
Novartis Investigative Site
Bielefeld, North Rhine-Westphalia, Germany
Novartis Investigative Site
Düsseldorf, North Rhine-Westphalia, Germany
Novartis Investigative Site
Essen, North Rhine-Westphalia, Germany
Novartis Investigative Site
Mönchengladbach, North Rhine-Westphalia, Germany
Novartis Investigative Site
Velbert, North Rhine-Westphalia, Germany
Novartis Investigative Site
Dresden, Saxony, Germany
Novartis Investigative Site
Lübeck, Schleswig-Holstein, Germany
Novartis Investigative Site
Augsburg, Germany
Novartis Investigative Site
Augsburg, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Bottrop, Germany
Novartis Investigative Site
Böblingen, Germany
Novartis Investigative Site
Dessau, Germany
Novartis Investigative Site
Erlangen, Germany
Novartis Investigative Site
Essen, Germany
Novartis Investigative Site
Hamburg, Germany
Novartis Investigative Site
Kiel, Germany
Novartis Investigative Site
Leipzig, Germany
Novartis Investigative Site
Mainz, Germany
Novartis Investigative Site
München, Germany
Novartis Investigative Site
Ravensburg, Germany
Novartis Investigative Site
Hong Kong, Hong Kong
Novartis Investigative Site
Kowloon, Hong Kong
Novartis Investigative Site
Tuenmen, Hong Kong
Novartis Investigative Site
Hyderabad, Andhra Pradesh, India
Novartis Investigative Site
Bangalore, Karnataka, India
Novartis Investigative Site
Mumbai, Maharashtra, India
Novartis Investigative Site
Pune, Maharasthra, India
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site
Bhubaneswar, Odisha, India
Novartis Investigative Site
Chennai, Tamil Nadu, India
Novartis Investigative Site
Kolkata, West Bengal, India
Novartis Investigative Site
Ahmedabad, India
Novartis Investigative Site
Beersheba, Israel
Novartis Investigative Site
Petah Tikva, Israel
Novartis Investigative Site
Ramat Gan, Israel
Novartis Investigative Site
Tel Aviv, Israel
Novartis Investigative Site
Alc Cuahutemoc, Mexico City, Mexico
Novartis Investigative Site
Tlalpan, Mexico City, Mexico
Novartis Investigative Site
Monterrey, Nuevo León, Mexico
Novartis Investigative Site
Coimbra, Portugal
Novartis Investigative Site
Lisbon, Portugal
Novartis Investigative Site
Lisbon, Portugal
Novartis Investigative Site
Porto, Portugal
Novartis Investigative Site
Porto, Portugal
Novartis Investigative Site
Porto, Portugal
Pan Oncology
Rio Piedras, Puerto Rico
Novartis Investigative Site
Bundang Gu, Gyeonggi-do, South Korea
Novartis Investigative Site
Gyeonggi-do, Korea, South Korea
Novartis Investigative Site
Incheon, Korea, South Korea
Novartis Investigative Site
Seoul, Korea, South Korea
Novartis Investigative Site
Seoul, Yangcheon Gu, South Korea
Novartis Investigative Site
Seongnam Gyeonggi, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Hualien City, Taiwan
Novartis Investigative Site
Kaohsiung City, Taiwan
Novartis Investigative Site
Tainan, Taiwan
Novartis Investigative Site
Taipei, Taiwan
Novartis Investigative Site
Taipei, Taiwan
Novartis Investigative Site
Sakarya, Adapazari, Turkey (Türkiye)
Novartis Investigative Site
Ankara, Bilkent-Cankaya, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Kadikoy, Turkey (Türkiye)
Novartis Investigative Site
Izmir, Karsiyaka, Turkey (Türkiye)
Novartis Investigative Site
Denizli, Kinikli, Turkey (Türkiye)
Novartis Investigative Site
Antalya, Konyaalti, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Sariyer, Turkey (Türkiye)
Novartis Investigative Site
Ankara, Sihhiye-Altindag, Turkey (Türkiye)
Novartis Investigative Site
Diyarbakır, Sur, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Uskudar, Turkey (Türkiye)
Novartis Investigative Site
Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site
Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site
Adana, Yuregir, Turkey (Türkiye)
Novartis Investigative Site
Ankara, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Turkey (Türkiye)
Novartis Investigative Site
Izmir, Turkey (Türkiye)
Novartis Investigative Site
Kecioren Ankara, Turkey (Türkiye)
Novartis Investigative Site
Konya, Turkey (Türkiye)
Novartis Investigative Site
Samsun, Turkey (Türkiye)